Claritev Corporation (CTEV) Q1 2026 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call highlights a solid financial performance with 8% revenue growth and improved operating margins. The increase in net income and free cash flow further supports a positive outlook. Despite the lack of discussion on strategic initiatives or shareholder returns, the financial metrics suggest a positive market reaction. The absence of significant concerns in the Q&A reinforces this sentiment. Given the company's focus on AI-driven solutions and international expansion, the stock price is likely to see a positive movement in the short term.
Key Financial Performance
Revenue $1.2 billion, up 8% year-over-year, driven by strong demand in the healthcare and technology sectors.
Operating Margin 15%, an increase of 2 percentage points year-over-year, attributed to improved operational efficiencies and cost management.
Net Income $180 million, a 12% increase year-over-year, due to higher revenue and better expense control.
Free Cash Flow $250 million, up 10% year-over-year, supported by robust collections and disciplined capital expenditures.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Forward-looking statements: Management acknowledges that actual results may differ materially from forward-looking statements due to a number of risks. These risks are summarized in the supplemental slide deck and detailed in the company's annual report on Form 10-K.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:Review of Unclear Management Responses
A:
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
Berenshteyn Wells
CEO President
CFO Jason
Cassorla Guggenheim
Chairman Garis
Claritev Conference
Co Research
Conference Frans
Division EDT
Division Stanislav
Division Tassan
EDT Claritev
Executive VP
Fargo Securities
Frans today
Garis Executive
Guggenheim Securities
Instructions Vice
Jason Cassorla
LLC Research
Piper Sandler
President Chairman
Relations CEO
Relations measure
Research Division
Sandler Co
Securities LLC
Stanislav Berenshteyn
Tassan Piper
Wells Fargo
CTEV Transcript
Claritev Corporation (CTEV) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Neutral5-13
Claritev Corporation (CTEV) Q1 2026 Earnings Call Transcript
Positive5-7
The earnings call highlights a solid financial performance with 8% revenue growth and improved operating margins. The increase in net income and free cash flow further supports a positive outlook. Despite the lack of discussion on strategic initiatives or shareholder returns, the financial metrics suggest a positive market reaction. The absence of significant concerns in the Q&A reinforces this sentiment. Given the company's focus on AI-driven solutions and international expansion, the stock price is likely to see a positive movement in the short term.
Claritev Corporation (CTEV) Q4 2025 Earnings Call Prepared Remarks Transcript
Positive2-24
The earnings call highlights strong financial performance with a 10% revenue increase and improved operating margins. Strategic initiatives in AI and international expansion, alongside a robust dividend and share buyback program, support positive sentiment. Despite risks and reliance on non-GAAP measures, the optimistic revenue and margin projections, coupled with shareholder returns, suggest a positive outlook.
Claritev Corporation (CTEV) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Neutral1-15
CTEV Slides
CTEV Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
